2024 Q2 Form 10-Q Financial Statement

#000163159624000017 Filed on April 23, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $156.5M $159.2M
YoY Change -6.08% 1.33%
Cost Of Revenue $108.8M $112.5M
YoY Change -5.93% 6.13%
Gross Profit $47.65M $46.76M
YoY Change -6.42% -8.61%
Gross Profit Margin 30.46% 29.36%
Selling, General & Admin $11.17M $11.33M
YoY Change -5.99% -12.99%
% of Gross Profit 23.44% 24.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $22.05M $50.15M
YoY Change -68.88% -34.23%
Operating Profit $25.60M -$3.388M
YoY Change -228.34% -86.49%
Interest Expense $108.8M $112.5M
YoY Change -5.93% 6.13%
% of Operating Profit 425.08%
Other Income/Expense, Net $7.220M $7.615M
YoY Change 3.56% 65.18%
Pretax Income $25.60M -$3.388M
YoY Change -228.34% -86.49%
Income Tax $100.0K $41.00K
% Of Pretax Income 0.39%
Net Earnings $25.83M -$8.739M
YoY Change -200.23% -65.15%
Net Earnings / Revenue 16.51% -5.49%
Basic Earnings Per Share $0.29 -$0.13
Diluted Earnings Per Share $0.29 -$0.13
COMMON SHARES
Basic Shares Outstanding 69.31M shares 69.31M shares
Diluted Shares Outstanding 69.42M shares 69.39M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $107.2M $106.5M
YoY Change -48.41% -58.08%
Cash & Equivalents $107.2M $106.5M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $36.45M $40.60M
Other Receivables $0.00 $0.00
Total Short-Term Assets $143.6M $147.1M
YoY Change -42.19% -50.18%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $117.3M $35.11M
YoY Change 230.46% -1.71%
Other Assets $67.66M $115.9M
YoY Change 246.96% 589.78%
Total Long-Term Assets $6.920B $7.110B
YoY Change -5.99% -6.22%
TOTAL ASSETS
Total Short-Term Assets $143.6M $147.1M
Total Long-Term Assets $6.920B $7.110B
Total Assets $7.064B $7.257B
YoY Change -7.17% -7.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.63M $14.11M
YoY Change 246.35% 280.23%
Accrued Expenses $16.70M $19.25M
YoY Change -15.95% -19.47%
Deferred Revenue
YoY Change
Short-Term Debt $223.4M $249.2M
YoY Change
Long-Term Debt Due $179.1M $110.9M
YoY Change
Total Short-Term Liabilities $458.2M $418.8M
YoY Change 640.97% 536.7%
LONG-TERM LIABILITIES
Long-Term Debt $5.159B $5.439B
YoY Change -15.2% -13.56%
Other Long-Term Liabilities $7.320M $18.49M
YoY Change 78.54% 340.17%
Total Long-Term Liabilities $5.166B $5.458B
YoY Change -15.14% -13.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $458.2M $418.8M
Total Long-Term Liabilities $5.166B $5.458B
Total Liabilities $5.625B $5.876B
YoY Change -8.54% -7.66%
SHAREHOLDERS EQUITY
Retained Earnings -$337.5M -$340.4M
YoY Change 31.08% 68.51%
Common Stock $693.0K $693.0K
YoY Change 0.29% 0.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.386B $1.381B
YoY Change
Total Liabilities & Shareholders Equity $7.064B $7.257B
YoY Change -7.17% -7.86%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $25.83M -$8.739M
YoY Change -200.23% -65.15%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $30.64M $34.49M
YoY Change -13.62% -17.17%
INVESTING ACTIVITIES
Capital Expenditures $1.455M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $229.5M $236.8M
YoY Change 33.04% -309.37%
Cash From Investing Activities $228.0M $236.8M
YoY Change 32.2% -309.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -264.8M -300.8M
YoY Change 5.34% -445.15%
NET CHANGE
Cash From Operating Activities 30.64M 34.49M
Cash From Investing Activities 228.0M 236.8M
Cash From Financing Activities -264.8M -300.8M
Net Change In Cash -6.114M -29.53M
YoY Change -85.91% -288.09%
FREE CASH FLOW
Cash From Operating Activities $30.64M $34.49M
Capital Expenditures $1.455M
Free Cash Flow $29.19M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
151620000 usd
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
152530000 usd
CY2024Q1 us-gaap Operating Lease Income Comprehensive Income Extensible List
OperatingLeaseIncomeComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#ProfitLossFromRealEstateOperations
CY2023Q1 us-gaap Operating Lease Income Comprehensive Income Extensible List
OperatingLeaseIncomeComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#ProfitLossFromRealEstateOperations
CY2024Q1 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
99977000 usd
CY2023Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
101017000 usd
CY2024Q1 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
82669000 usd
CY2023Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
82091000 usd
CY2024Q1 us-gaap Interest Receivable
InterestReceivable
40602000 usd
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
41003000 usd
CY2024Q1 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
35108000 usd
CY2023Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
35076000 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
22200000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
19455000 usd
CY2024Q1 us-gaap Assets
Assets
7256695000 usd
CY2023Q4 us-gaap Assets
Assets
7547618000 usd
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
3521796000 usd
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
3782419000 usd
CY2024Q1 kref Collateralized Loan Obligations Net
CollateralizedLoanObligationsNet
1942569000 usd
CY2023Q4 kref Collateralized Loan Obligations Net
CollateralizedLoanObligationsNet
1942171000 usd
CY2024Q1 us-gaap Secured Debt
SecuredDebt
334977000 usd
CY2023Q4 us-gaap Secured Debt
SecuredDebt
335331000 usd
CY2024Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
19247000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
20207000 usd
CY2024Q1 kref Real Estate Owned Liabilities Held For Sale
RealEstateOwnedLiabilitiesHeldForSale
16334000 usd
CY2023Q4 kref Real Estate Owned Liabilities Held For Sale
RealEstateOwnedLiabilitiesHeldForSale
15883000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
5876605000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
6143436000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75299556 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75299556 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69313860 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69313860 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
693000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
693000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1817373000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1815077000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-340437000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-314370000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5985696 shares
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5985696 shares
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
96764000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
96764000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1380996000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1404767000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
-906000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-585000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1380090000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1404182000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7256695000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7547618000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
112476000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
105976000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
39144000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
46554000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
845000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-347000 usd
CY2024Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1792000 usd
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2711000 usd
CY2024Q1 us-gaap Profit Loss From Real Estate Operations
ProfitLossFromRealEstateOperations
4978000 usd
CY2023Q1 us-gaap Profit Loss From Real Estate Operations
ProfitLossFromRealEstateOperations
2246000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7615000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4610000 usd
CY2024Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
33266000 usd
CY2023Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
60467000 usd
CY2024Q1 kref Management Fee To Affiliate
ManagementFeeToAffiliate
6340000 usd
CY2023Q1 kref Management Fee To Affiliate
ManagementFeeToAffiliate
6523000 usd
CY2024Q1 us-gaap Noninterest Expense Related To Performance Fees
NoninterestExpenseRelatedToPerformanceFees
0 usd
CY2023Q1 us-gaap Noninterest Expense Related To Performance Fees
NoninterestExpenseRelatedToPerformanceFees
1811000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4992000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4690000 usd
CY2024Q1 kref Property Operating Expense
PropertyOperatingExpense
5549000 usd
CY2023Q1 kref Property Operating Expense
PropertyOperatingExpense
2758000 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
50147000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
76249000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3388000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25085000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
169000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-3429000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-25254000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-321000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-177000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3108000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-25077000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5326000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5326000 usd
CY2024Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
305000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
407000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8739000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8739000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30810000 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69386568 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69386568 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69095011 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69095011 shares
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2024Q1 kref Participating Security Dividends Per Share Declared
ParticipatingSecurityDividendsPerShareDeclared
0.25
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2023Q1 kref Participating Security Dividends Per Share Declared
ParticipatingSecurityDividendsPerShareDeclared
0.43
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-3429000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-25254000 usd
CY2024Q1 kref Accretion Of Deferred Loan Costs And Discounts
AccretionOfDeferredLoanCostsAndDiscounts
4724000 usd
CY2023Q1 kref Accretion Of Deferred Loan Costs And Discounts
AccretionOfDeferredLoanCostsAndDiscounts
5888000 usd
CY2024Q1 kref Payments For Interest Paid In Kind
PaymentsForInterestPaidInKind
25000 usd
CY2023Q1 kref Payments For Interest Paid In Kind
PaymentsForInterestPaidInKind
0 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5029000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6796000 usd
CY2024Q1 kref Increase Decreasein Equity Method Investments
IncreaseDecreaseinEquityMethodInvestments
32000 usd
CY2023Q1 kref Increase Decreasein Equity Method Investments
IncreaseDecreaseinEquityMethodInvestments
-1130000 usd
CY2024Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
33266000 usd
CY2023Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
60467000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2296000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2152000 usd
CY2024Q1 kref Increase Decrease In Net Assets Related To Real Estate Owned Held For Sale
IncreaseDecreaseInNetAssetsRelatedToRealEstateOwnedHeldForSale
3023000 usd
CY2023Q1 kref Increase Decrease In Net Assets Related To Real Estate Owned Held For Sale
IncreaseDecreaseInNetAssetsRelatedToRealEstateOwnedHeldForSale
0 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-401000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1507000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-499000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-658000 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-960000 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3841000 usd
CY2024Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
-183000 usd
CY2023Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
-155000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-673000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-605000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34488000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
41635000 usd
CY2024Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
334680000 usd
CY2023Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
89669000 usd
CY2024Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
95814000 usd
CY2023Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
201881000 usd
CY2024Q1 kref Payments For Capital Expenditures Real Estate Owned
PaymentsForCapitalExpendituresRealEstateOwned
2110000 usd
CY2023Q1 kref Payments For Capital Expenditures Real Estate Owned
PaymentsForCapitalExpendituresRealEstateOwned
868000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
236756000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-113080000 usd
CY2024Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
118754000 usd
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
162436000 usd
CY2024Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
255000 usd
CY2024Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
382144000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
39592000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2249000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
919000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
29805000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
29711000 usd
CY2024Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
5326000 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
5326000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-300770000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
87143000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29526000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15698000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148313000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
250621000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118787000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
266319000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106517000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
254096000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
12270000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
12223000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118787000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
266319000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
108407000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
95339000 usd
CY2024Q1 us-gaap Dividends
Dividends
17328000 usd
CY2023Q1 us-gaap Dividends
Dividends
29711000 usd
CY2024Q1 us-gaap Escrow Deposits Related To Property Sales
EscrowDepositsRelatedToPropertySales
7325000 usd
CY2023Q1 us-gaap Escrow Deposits Related To Property Sales
EscrowDepositsRelatedToPropertySales
0 usd
CY2024Q1 kref Loan Principal Payments Held By A Servicer
LoanPrincipalPaymentsHeldByAServicer
3500000 usd
CY2023Q1 kref Loan Principal Payments Held By A Servicer
LoanPrincipalPaymentsHeldByAServicer
0 usd
CY2024Q1 kref Deferred Financing Costs Incurred But Not Yet Paid
DeferredFinancingCostsIncurredButNotYetPaid
2060000 usd
CY2023Q1 kref Deferred Financing Costs Incurred But Not Yet Paid
DeferredFinancingCostsIncurredButNotYetPaid
2331000 usd
CY2024Q1 kref Loan Modification Accounted For New Loan
LoanModificationAccountedForNewLoan
0 usd
CY2023Q1 kref Loan Modification Accounted For New Loan
LoanModificationAccountedForNewLoan
111000000 usd
CY2024Q1 kref Debt Instrument Covenant Liquidity Required Cashand Cash Equivalents
DebtInstrumentCovenantLiquidityRequiredCashandCashEquivalents
56500000 usd
CY2023Q4 kref Debt Instrument Covenant Liquidity Required Cashand Cash Equivalents
DebtInstrumentCovenantLiquidityRequiredCashandCashEquivalents
60200000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
12300000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
12400000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— The preparation of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condensed consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condensed consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements and the reported amounts of revenue and expenses during the reporting period. Management makes subjective estimates to project cash flows KREF expects to receive on its investments in loans and securities as well as the related market discount rates, which significantly impact the interest income, impairments, allowance for loan loss and fair values recorded or disclosed. Actual results could materially differ from those estimates.</span></div>
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
7343548000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
210470000 usd
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
7133078000 usd
CY2024Q1 us-gaap Mortgage Loans On Real Estate New Mortgage Loans
MortgageLoansOnRealEstateNewMortgageLoans
103139000 usd
CY2024Q1 us-gaap Mortgage Loans On Real Estate New Mortgage Loans
MortgageLoansOnRealEstateNewMortgageLoans
103139000 usd
CY2024Q1 srt Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
338180000 usd
CY2024Q1 srt Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
338180000 usd
CY2024Q1 kref Mortgage Loanson Real Estate Amortizationof Premium Discount Net
MortgageLoansonRealEstateAmortizationofPremiumDiscountNet
-4724000 usd
CY2024Q1 kref Mortgage Loanson Real Estate Amortizationof Premium Discount Net
MortgageLoansonRealEstateAmortizationofPremiumDiscountNet
-4724000 usd
CY2024Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
25000 usd
CY2024Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
25000 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
33164000 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
33164000 usd
CY2024Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
7113256000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
243634000 usd
CY2024Q1 us-gaap Notes Receivable Net
NotesReceivableNet
6869622000 usd
CY2024Q1 kref Mortgage Loan On Real Estate Funding Held In Escrow
MortgageLoanOnRealEstateFundingHeldInEscrow
7300000 usd
CY2024Q1 kref Interest Collections On Loan Amortized Cost
InterestCollectionsOnLoanAmortizedCost
2500000 usd
CY2024Q1 kref Prepayment Fee Income
PrepaymentFeeIncome
0 usd
CY2024Q1 kref Net Accelerated Fee Income
NetAcceleratedFeeIncome
0 usd
CY2023Q1 kref Prepayment Fee Income
PrepaymentFeeIncome
400000 usd
CY2023Q1 kref Net Accelerated Fee Income
NetAcceleratedFeeIncome
300000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
243634000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
210470000 usd
CY2023Q4 kref Weighted Average Loan Risk Rating
WeightedAverageLoanRiskRating
3.2
CY2024Q1 kref Weighted Average Loan Risk Rating
WeightedAverageLoanRiskRating
3.2
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
0 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
210470000 usd
CY2023Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
2052000 usd
CY2023Q4 kref Allowance For Credit Loss
AllowanceForCreditLoss
212522000 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
33164000 usd
CY2024Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
102000 usd
CY2024Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
33266000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
243634000 usd
CY2024Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
2154000 usd
CY2024Q1 kref Allowance For Credit Loss
AllowanceForCreditLoss
245788000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
106974000 usd
CY2022Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
4138000 usd
CY2022Q4 kref Allowance For Credit Loss
AllowanceForCreditLoss
111112000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
60386000 usd
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
81000 usd
CY2023Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
60467000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
167360000 usd
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
4219000 usd
CY2023Q1 kref Allowance For Credit Loss
AllowanceForCreditLoss
171579000 usd
CY2024Q1 kref Allowance For Credit Loss
AllowanceForCreditLoss
245800000 usd
CY2024Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
33300000 usd
CY2023Q1 kref Allowance For Credit Loss
AllowanceForCreditLoss
171600000 usd
CY2023Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
60500000 usd
CY2024Q1 us-gaap Proceeds From Real Estate And Real Estate Joint Ventures
ProceedsFromRealEstateAndRealEstateJointVentures
1300000 usd
CY2024Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
4370000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1670000 usd
CY2024Q1 kref Other Real Estate Operations Income
OtherRealEstateOperationsIncome
608000 usd
CY2023Q1 kref Other Real Estate Operations Income
OtherRealEstateOperationsIncome
576000 usd
CY2024Q1 kref Property Operating Revenue
PropertyOperatingRevenue
4978000 usd
CY2023Q1 kref Property Operating Revenue
PropertyOperatingRevenue
2246000 usd
CY2024Q1 kref Property Operating Expense
PropertyOperatingExpense
5549000 usd
CY2023Q1 kref Property Operating Expense
PropertyOperatingExpense
2758000 usd
CY2024Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
13000 usd
CY2023Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
288000 usd
CY2024Q1 kref Income Loss From Real Estate Owned Operations
IncomeLossFromRealEstateOwnedOperations
-558000 usd
CY2023Q1 kref Income Loss From Real Estate Owned Operations
IncomeLossFromRealEstateOwnedOperations
-224000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17000 usd
CY2024Q1 us-gaap Amortization Of Below Market Lease
AmortizationOfBelowMarketLease
91000 usd
CY2023Q1 us-gaap Amortization Of Below Market Lease
AmortizationOfBelowMarketLease
91000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
50000 usd
CY2024Q1 us-gaap Below Market Lease Amortization Income Remainder Of Fiscal Year
BelowMarketLeaseAmortizationIncomeRemainderOfFiscalYear
274000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
67000 usd
CY2024Q1 us-gaap Below Market Lease Amortization Income Next Twelve Months
BelowMarketLeaseAmortizationIncomeNextTwelveMonths
365000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
67000 usd
CY2024Q1 us-gaap Below Market Lease Amortization Income Year Two
BelowMarketLeaseAmortizationIncomeYearTwo
365000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
11105000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
10950000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
8968000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
7558000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
5913000 usd
CY2024Q1 kref Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
19991000 usd
CY2024Q1 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateral
0.338
CY2023Q4 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateral
0.338
CY2024Q1 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral Percentageif Maximum Amountis Borrowed
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateralPercentageifMaximumAmountisBorrowed
0.312
CY2023Q4 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral Percentageif Maximum Amountis Borrowed
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateralPercentageifMaximumAmountisBorrowed
0.322
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
149794000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
175594000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1737592000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1347252000 usd
CY2024Q1 kref Long Term Debt Maturity After Year Three
LongTermDebtMaturityAfterYearThree
121319000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3531551000 usd
CY2024Q1 kref Debt Instrument Covenant Interest Incometo Interest Expense Ratio
DebtInstrumentCovenantInterestIncometoInterestExpenseRatio
1.4
CY2024Q1 kref Debt Instrument Covenant Consolidated Tangible Net Worth Minimum Percentage Of Aggregate Cash Proceeds Made And Capital Contributions Received
DebtInstrumentCovenantConsolidatedTangibleNetWorthMinimumPercentageOfAggregateCashProceedsMadeAndCapitalContributionsReceived
0.750
CY2024Q1 kref Debt Instrument Covenant Consolidated Tangible Net Worth Amountof Aggregate Cash Proceeds Madeand Capital Contributions Received
DebtInstrumentCovenantConsolidatedTangibleNetWorthAmountofAggregateCashProceedsMadeandCapitalContributionsReceived
1307700000 usd
CY2024Q1 kref Debt Instrument Covenant Cash Liquidity Amount
DebtInstrumentCovenantCashLiquidityAmount
10000000 usd
CY2024Q1 kref Debt Instrument Covenant Cash Liquidity Percentof Recourse Indebtedness
DebtInstrumentCovenantCashLiquidityPercentofRecourseIndebtedness
0.050
CY2024Q1 kref Debt Instrument Covenant Total Indebtedness Percentof Total Assets
DebtInstrumentCovenantTotalIndebtednessPercentofTotalAssets
0.833
CY2024Q1 kref Collateral Assets Under Collateralized Loan Obligations As A Percentage Of Commercial Mortgage Loans
CollateralAssetsUnderCollateralizedLoanObligationsAsAPercentageOfCommercialMortgageLoans
0.320
CY2024Q1 kref Percentage Of Collateralized Loan Obligations Under Floating Rate Loans
PercentageOfCollateralizedLoanObligationsUnderFloatingRateLoans
1
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
12270000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
12415000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3636000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3747000 usd
CY2024Q1 kref Loan Principal Payments Held By A Servicer Asset
LoanPrincipalPaymentsHeldByAServicerAsset
3500000 usd
CY2023Q4 kref Loan Principal Payments Held By A Servicer Asset
LoanPrincipalPaymentsHeldByAServicerAsset
0 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
2794000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
3293000 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
22200000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
19455000 usd
CY2024Q1 kref Real Estate Owned Held For Investment Liability
RealEstateOwnedHeldForInvestmentLiability
4952000 usd
CY2023Q4 kref Real Estate Owned Held For Investment Liability
RealEstateOwnedHeldForInvestmentLiability
5363000 usd
CY2024Q1 kref Unfunded Commitments Allowance For Credit Loss
UnfundedCommitmentsAllowanceForCreditLoss
2153000 usd
CY2023Q4 kref Unfunded Commitments Allowance For Credit Loss
UnfundedCommitmentsAllowanceForCreditLoss
2052000 usd
CY2024Q1 kref Loan Funding Held In Escrow Liability
LoanFundingHeldInEscrowLiability
7325000 usd
CY2023Q4 kref Loan Funding Held In Escrow Liability
LoanFundingHeldInEscrowLiability
0 usd
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1837000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1935000 usd
CY2014Q4 kref Common Stockand Preferred Stock Shares Authorized
CommonStockandPreferredStockSharesAuthorized
350000000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75299556 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75299556 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69313860 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69313860 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5985696 shares
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5985696 shares
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
100000000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
17328000 usd
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
17328000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
29711000 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
29711000 usd
CY2024Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
5326000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
5326000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39369 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20426 shares
CY2023Q1 kref Incremental Common Shares Potentially Attributable To Dilutive Effect Of Conversion Of Debt Securities
IncrementalCommonSharesPotentiallyAttributableToDilutiveEffectOfConversionOfDebtSecurities
6316174 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3108000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-25077000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5326000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5326000 usd
CY2024Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
305000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
407000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8739000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8739000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30810000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-30810000 usd
CY2024Q1 kref Weighted Average Number Of Shares Outstanding Excluding Vested But Undistributed Restricted Stock Units Basic
WeightedAverageNumberOfSharesOutstandingExcludingVestedButUndistributedRestrictedStockUnitsBasic
69313860 shares
CY2023Q1 kref Weighted Average Number Of Shares Outstanding Excluding Vested But Undistributed Restricted Stock Units Basic
WeightedAverageNumberOfSharesOutstandingExcludingVestedButUndistributedRestrictedStockUnitsBasic
69095011 shares
CY2024Q1 kref Incremental Common Shares Attributable To Deferred Stock Units
IncrementalCommonSharesAttributableToDeferredStockUnits
72708 shares
CY2023Q1 kref Incremental Common Shares Attributable To Deferred Stock Units
IncrementalCommonSharesAttributableToDeferredStockUnits
0 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69386568 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69095011 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2022Q1 kref Number Of Times Interest Rates Increased
NumberOfTimesInterestRatesIncreased
11 time
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
243600000 usd
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
6851540000 usd
CY2024Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
200000 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2024Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd

Files In Submission

Name View Source Status
0001631596-24-000017-index-headers.html Edgar Link pending
0001631596-24-000017-index.html Edgar Link pending
0001631596-24-000017.txt Edgar Link pending
0001631596-24-000017-xbrl.zip Edgar Link pending
a202403-exhibit311.htm Edgar Link pending
a202403-exhibit312.htm Edgar Link pending
a202403-exhibit321.htm Edgar Link pending
a202403-exhibit322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kref-20240331.htm Edgar Link pending
kref-20240331.xsd Edgar Link pending
kref-20240331_g1.jpg Edgar Link pending
kref-20240331_g2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kref-20240331_cal.xml Edgar Link unprocessable
kref-20240331_def.xml Edgar Link unprocessable
kref-20240331_pre.xml Edgar Link unprocessable
kref-20240331_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
kref-20240331_lab.xml Edgar Link unprocessable